PIDS EPM 2020-2021
Reset and Rebuild for a Better Philippines in the Post-pandemic World
DLSU-AKI Working Paper Series 2021-11-079
Examining and Evaluating the Multidimensional Energy Poverty Index (MEPI) in the Philippine Household Context
DLSU-AKI Working Paper Series 2021-11-078
A Game Theoretic Study on CSR and Government Intervention for Sustainable Production
DLSU-AKI Working Paper Series 2021-11-077
Obstacles to Economic Freedom Affecting Micro, Small, and Medium Enterprises (MSMEs) in Southeast Asian Countries

PIDS WB 2021-1104
Assessing the Philippines' Performance in Meeting the ASEAN Economic Community Vision 2025
PIDS WB 2021-1103
Examining The Health Impacts Of The COVID-19 Pandemic In The Philippines
ILS 30th Anniversary Video
PIDS WB 2021-1102
Evaluating the Pantawid Pamilyang Pilipino Program's Payment System
Publication Detail
DP 2012-13: Review of the Cheaper Medicines Program of the Philippines: Botika ng Barangay, Botika ng Bayan, P100 Treatment Pack, and the Role of PITC Pharma, Inc. in Government Drug Procurement

This report provides an assessment of the Department of Health`s (DOH) three drug provision programs, i.e., Botika ng Barangay (BnB), Botika ng Bayan (BNB), and the P100 Treatment Pack (P100). (a) The BnB program expanded its distribution network rapidly in the past decade, contributing to improvement in market contestability. The BnBs showed that generic drug retailing can have modest profitability in rural areas, thus encouraging the private sector to enter the market aggressively, eventually outpricing some of the BnBs. In addition, while the number of BnBs has grown rapidly, not all of them have been provided with sufficient financial and management support to make them sustainable. DOH has taken cognizance of the problem and has instituted a moratorium on further BnB expansion until problems in restocking and financing are addressed. (b) BNBs are private franchises supported by the PITC Pharma Inc., a government parastatal. They are more sustainable than BnBs, but are facing aggressive competition from private franchisors which are able to offer better terms to their franchisees. (c) The P100 Treatment Pack operates on the principle of improving patient compliance to treatment through less expensive generic drug packs. Introduced in 2009, the program initially showed significant patient savings compared to private sector generic equivalents. The problem is its underfunding, poor reporting of sold items by participating hospitals, short drug list, and limited outlets. Since then, aggressive private sector generic retailers have entered the market offering similar treatment packs. The program is planned to be configured as a primary care pharmacy benefit under PhilHealth.

Philippine Institute for Development Studies
Authors Keywords
Picazo, Oscar F.; Philippines; Botika ng Barangay; Botika ng Bayan; pharmaceuticals; Treatment Pack; Cheaper Medicines Program;
Download PDF Number of Downloads
Published in 2012 and available in the PIDS Library or Downloaded 1,623 times since September 13, 2012
Please let us know your reason for downloading this publication. May we also ask you to provide additional information that will help us serve you better? Rest assured that your answers will not be shared with any outside parties. It will take you only two minutes to complete the survey. You will answer the profile questions only once as long as you enter the same email address. Thank you.

To use as reference:
If others, (Please specify):
Name: (optional)
Email: (required, but will not display; please use the same email address when downloading another publication so that the profile questions will not appear)
If Prefer to self-describe, please specify:
Level of Education:
If employed either part-time or full-time, name of office:
If others, (Please specify):
Would you like to receive the SERP-P UPDATES e-newsletter? Yes No
Use the space below if you have any comment about this publication or SERP-P knowledge resources in general.